Genetics and tuberculosis oials become available, observational research using cohort or case-control tech-D r Richard Bellamy alludes to the important .iques remains an important source of fact, frequently ignored by immunologists, &dence about the safety of drugs.
geneticists and epidemiologists, that tuberThirdly, he states that a review by Astra culosis has several different clinical forms.' Draco has found no evidence from PrePhysicians have emphasised the difference marketing or post-marketing studies of an between primary tuberculosis, which is comassociation between bambuterol and cardiac parable to Lurie's susceptible rabbits with failure. In general, pre-marketing studies disseminated disease, and post primary have their own limitations,' as evidenced by tuberculosis, best characterised by smear the recent withdrawal On losir restricted antigens were higher, suggestis possible that the association may be ing an enhanced immune responsiveness in explained by factors such as confounding by those with HLA-DR15.' T h e relative concomitant disease and disease severity.
importance of the genes involved in susceptiInterestingly, the rate of cardiac failure biliry can be assessed by the gene frequency, associated with bambuterol in the first but also by the attributable risk-that is, how month of treatment was higher than for 11 much of the disease can be attributed to the cardiovascular drugs previously studied by presence or absence of a particular gene PEM ( 
Chlamydia pneumoniae and asthma
T h e paper by Cook et all examines the possible association between Chlamydia pneumoniae infection and asthma. T h e authors conclude that their data do not support this association. However, we feel that the serological tests performed give important information on the prevalence of infection, but are not suficiently complete to make definitive conclusions on the incidence of acute C pneumoniae infection in the populations under study. The major pitfall in the study, as pointed out by the authors, is the small proportion of patients from whom a convalescent serum sample was drawn. Moreover, the arbitrary exclusion of IgM positive patients for the diagnosis of acute Cpneumoniae infection may have been misleading since the possibility of cross reactivity with rheumatoid factor could have been effectively ruled out by using IgG absorption prior to IgM microimmunofluorescence determination.' Notwithstanding these facts, the authors conclude that the study does not support "an association between C pneun~oniae antibody titres and the incidence of acute asthma attacks". Analysis of table 1 indicates that the acute asthma and control populations appear to be significantly different in terms of age and sex distribution, the control population being significantly older and showing a male predominance. Both these factors are associated with increased C pnelrmotztae incidence and prevalence. T h e authors report using a logistic regression modelling method in which the age value is implemented as "+ 10 years", which is roughly equivalent to the difference in mean age between the acute asthma and control populations.
This study is certainly noteworthy in that it underlines an association between C pneunloniae infection and severe chronic asthma, particularly "brittle" asthma, which will require further investigation in the future. 
Non-Hodgkin's lymphoma with CFA
We read with interest the case report by Orchard er a1 on non-Hodgkin's lymphoma arising in cryptogenic fibrosing alveolitis (CFA).' Although the authors state that this has not been described previously, we recently reported six cases of pulmonary B cell non-Hodgkin's lymphomas arising in patients with autoimmune disorders, three of whom had CFA.' As in the case described by Orchard er al, prognosis in these three patients was much poorer than that in the patients with high grade pulmonary nonHodgkin's lymphomas unassociated with CFA, presumably due to the combined effects of the two diseases.
ANDREW NICHOLSON AL'THOR'S REPLY
We are grateful to Dr Nicholson and Professor Corrin for pointing out their very interesting report, which was published after the original writing of our case report.
I n the patient we reported the association was with cryptogenic fibrosing alveolitis (CFA) alone whereas, interestingly, the three patients they report had CFA associated with other systemic autoimmune disorders. The fact that CFA alone may be associated with B cell lymphomas, and the poorer prognosis seen by Nicholson and Corrin in their patients, as well as ours, supports the hypothesis that chronic local stimulation of the lymphoid system may play an important part in the aetiology and prognosis of these tumours. This is the third edition of an established book. Aiming to bring together all the recent information on basic mechanisms of asthma and also cover clinical aspects and therapy in depth, this is achieved successfully. The scope of the book provides accessible reviews of all facets of asthma, from epidemiology and physiology to allergen avoidance, including recent developments in these fields. Modifications to the popular second edition include separate chapters on mediator antagonists and immunomodulators with consideration of the potential therapeutic benefits of intervening in the complex inflammatory and pharmacological pathways systematically covered in previous chapters. A new chapter on the pharmacoeconomics of asthma treatments provides a pertinent reminder that, after the wonders of basic science and the development of beneficial interventions, a wider perspective is required to successfully deliver benefits to those who require them. The addition of colour plates provides a welcome change to the previous black and white prints of the old edition which look a little drab in retrospect.
Well written by authorities in their fields and uniformly edited with an attractive presentation, this is an excellent book which succeeds in linking the rapidly developing body of knowledge on asthma with current treatment, while keeping the future constantly in A large amount of information has been packed into the 184 pages of this new guidebook in the Principles and Practice Series. This is a comprehensive review of the principles of ventilation and gas exchange with special emphasis on the application of pulmonary function measurement during anaesthesia. The book details physiological principles and gives practical measurement guidance, with common sources of error, in the normal circumstances and during anaesthesia. The content is concise, the style direct and occasionally hard going. T h e text is clear and the diagrams are worth a special mention for their clarity and simplicity. This is not a textbook for beginners and requires a moderate familiarity with the principles of respiratory physiology, and the rules which govern respiratory mechanics and gas measurement. This guide represents excellent value for money and would be equally at home in the pulmonary function laboratory as well as the anaesthetics department. -SR CORRECTION Clinical features of non-smokers with a,-antitrypsin deficiency The authors of the paper entitled "Clinical features and prognosis of life time nonsmokers with severe a,-antitrypsin deficiency" by N Seersholm and A Kok-Jensen, which appeared on pages 265-8 of the April issue of Thorax, regret that some errors occurred in the text and in table 3. On page 267 the first line of column 1 should have read: ". . . 50 years at entry was 56% compared with 50% for the subjects over 50 years . . .". Table 3 is reproduced here with the corrections shown in bold italics. 
